Directing the immune response to carbohydrate antigens

Area of Science:

• Immunology
• Vaccine Design
• Biochemistry

Background:

• Carbohydrate antigens are crucial in vaccine design, but their structural and immunological mimicry by peptides remains poorly understood.
• Current methods for identifying peptide mimetics often rely on screening display libraries, which may not capture functional aspects effectively.

Purpose of the Study:

• To demonstrate a structure-assisted vaccine design approach for identifying functional mimeotopes.
• To investigate the potential of peptide mimetics as substitutes for carbohydrate antigens in vaccine applications, particularly against HIV-1.

Main Methods:

• Utilized concanavalin A (ConA) as a recognition template to identify ConA-reactive peptide mimetics.
• Employed enzyme-linked immunosorbent assay (ELISA) and isothermal titration calorimetry (ITC) to assess peptide-ConA binding and affinity.
• Evaluated cellular and humoral immune responses in mice immunized with identified mimeotopes, including T-cell responses and antibody binding to HIV-1-infected cells.

Main Results:

• Identified designed peptides that compete with carbohydrate probes for ConA binding, with a multivalent mimetic showing affinity comparable to trimannoside.
• Demonstrated a peptide-specific, T-cell-dependent cellular response in splenocytes from mimeotope-immunized mice.
• Showed that mimeotope-induced serum binds to HIV-1-infected cells and exhibits low-titer in vitro neutralization of HIV-1.

Conclusions:

• Mimicry in vaccine design is governed more by functional than structural determinants, influencing T-dependent antibody responses to polysaccharides.
• A rational, structure-assisted approach is feasible for developing functional mimeotopes and potential vaccine candidates.
• Peptide mimetics show promise for developing vaccines targeting carbohydrate-binding pathogens like HIV-1.